Inventor
MOSHER GEROLD L
US67 patents
⚠️ This page may combine multiple inventors who share the name “MOSHER GEROLD L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SILVERGATE PHARMACEUTICALS INC
23 patentsUS9616096B1Apr 11, 2017
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC23 citations98
US9463183B1Oct 11, 2016
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC35 citations98
US10695329B2Jun 30, 2020
Amlodipine formulations
SILVERGATE PHARMACEUTICALS INC14 citations94
US11179434B2Nov 23, 2021
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC7 citations92
US10940177B2Mar 9, 2021
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC8 citations92
US10406199B2Sep 10, 2019
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC8 citations92
US10265370B2Apr 23, 2019
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC10 citations92
US10039800B2Aug 7, 2018
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC12 citations92
US9814751B2Nov 14, 2017
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC13 citations92
US9808442B2Nov 7, 2017
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC8 citations92
US9669008B1Jun 6, 2017
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC13 citations92
US11771733B2Oct 3, 2023
Lisinopril formulations
SILVERGATE PHARMACEUTICALS INC4 citations86
US11040023B2Jun 22, 2021
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC2 citations84
US10959991B2Mar 30, 2021
Amlodipine formulations
SILVERGATE PHARMACEUTICALS INC4 citations84
US10952998B2Mar 23, 2021
Amlodipine formulations
SILVERGATE PHARMACEUTICALS INC6 citations84
US10918621B2Feb 16, 2021
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC3 citations84
US10894039B2Jan 19, 2021
Amlodipine formulations
SILVERGATE PHARMACEUTICALS INC8 citations84
US10799453B2Oct 13, 2020
Amlodipine formulations
SILVERGATE PHARMACEUTICALS INC7 citations84
US10799476B2Oct 13, 2020
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC3 citations84
US10772868B2Sep 15, 2020
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC3 citations84
US10154987B2Dec 18, 2018
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC3 citations84
US10039745B2Aug 7, 2018
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC4 citations84
US10786482B2Sep 29, 2020
Enalapril formulations
SILVERGATE PHARMACEUTICALS INC1 citations73
CYDEX PHARMACEUTICALS INC
11 patentsUS7629331B2Dec 8, 2009
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC68 citations97
US8343995B2Jan 1, 2013
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
CYDEX PHARMACEUTICALS INC17 citations91
US9617352B2Apr 11, 2017
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC3 citations84
US8829182B2Sep 9, 2014
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC7 citations84
US8049003B2Nov 1, 2011
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC18 citations84
US9399067B2Jul 26, 2016
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
CYDEX PHARMACEUTICALS INC7 citations83
US10159752B2Dec 25, 2018
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CYDEX PHARMACEUTICALS INC4 citations82
US9125945B2Sep 8, 2015
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
CYDEX PHARMACEUTICALS INC4 citations82
US8853236B2Oct 7, 2014
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
CYDEX PHARMACEUTICALS INC5 citations82
US10703826B2Jul 7, 2020
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC1 citations73
US10202468B2Feb 12, 2019
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
CYDEX PHARMACEUTICALS INC2 citations73
AZURITY PHARMACEUTICALS INC
8 patentsUS12186360B2Jan 7, 2025
Lisinopril formulations
AZURITY PHARMACEUTICALS INC2 citations86
US11918685B2Mar 5, 2024
Amlodipine formulations
AZURITY PHARMACEUTICALS INC3 citations85
US11701326B2Jul 18, 2023
Amlodipine formulations
AZURITY PHARMACEUTICALS INC4 citations85
US12128083B2Oct 29, 2024
Lisinopril formulations
AZURITY PHARMACEUTICALS INC2 citations84
US11484498B2Nov 1, 2022
Amlodipine formulations
AZURITY PHARMACEUTICALS INC4 citations84
US11471409B2Oct 18, 2022
Amlodipine formulations
AZURITY PHARMACEUTICALS INC4 citations84
US11364230B2Jun 21, 2022
Amlodipine formulations
AZURITY PHARMACEUTICALS INC4 citations84
US12053461B2Aug 6, 2024
Amlodipine formulations
AZURITY PHARMACEUTICALS INC1 citations73
CYDEX INC
3 patentsUS6046177AApr 4, 2000
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
CYDEX INC418 citations98
US7034013B2Apr 25, 2006
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
CYDEX INC105 citations96
US6869939B2Mar 22, 2005
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
CYDEX INC42 citations89
MOSHER GEROLD L
3 patentsUS8835407B2Sep 16, 2014
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
MOSHER GEROLD L117 citations97
US8236782B2Aug 7, 2012
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
MOSHER GEROLD L30 citations91
US8846901B2Sep 30, 2014
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
MOSHER GEROLD L5 citations83
PIPKIN JAMES D
1 patentLILLY CO ELI
1 patentShowing the top 50 of 67 patents by PatentIndex Score.